25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MEDIF (Medipharm Labs Corp) Stock Analysis
Buy, Hold or Sell?

Let's analyze Medipharm Labs Corp together

I guess you are interested in Medipharm Labs Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Medipharm Labs Corp’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Medipharm Labs Corp’s Price Targets

I'm going to help you getting a better view of Medipharm Labs Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Medipharm Labs Corp

I send you an email if I find something interesting about Medipharm Labs Corp.

1. Quick Overview

1.1. Quick analysis of Medipharm Labs Corp (30 sec.)










1.2. What can you expect buying and holding a share of Medipharm Labs Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.08
Expected worth in 1 year
$0.06
How sure are you?
35.7%

+ What do you gain per year?

Total Gains per Share
$-0.01
Return On Investment
-23.4%

For what price can you sell your share?

Current Price per Share
$0.05
Expected price per share
$0.038 - $0.081
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Medipharm Labs Corp (5 min.)




Live pricePrice per Share (EOD)
$0.05
Intrinsic Value Per Share
$0.08 - $0.10
Total Value Per Share
$0.16 - $0.18

2.2. Growth of Medipharm Labs Corp (5 min.)




Is Medipharm Labs Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$31.5m$39.6m-$6.9m-21.2%

How much money is Medipharm Labs Corp making?

Current yearPrevious yearGrowGrow %
Making money-$1.3m-$2.4m$1.1m82.1%
Net Profit Margin-17.8%-37.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Medipharm Labs Corp (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Medipharm Labs Corp?

Welcome investor! Medipharm Labs Corp's management wants to use your money to grow the business. In return you get a share of Medipharm Labs Corp.

First you should know what it really means to hold a share of Medipharm Labs Corp. And how you can make/lose money.

Speculation

The Price per Share of Medipharm Labs Corp is $0.0498. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medipharm Labs Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medipharm Labs Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.08. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medipharm Labs Corp.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-1.4%0.00-6.6%-0.01-12.0%-0.01-13.0%-0.01-27.5%-0.01-22.3%
Usd Book Value Change Per Share0.000.2%0.00-5.9%0.00-3.4%0.00-9.7%-0.01-13.2%0.005.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.2%0.00-5.9%0.00-3.4%0.00-9.7%-0.01-13.2%0.005.5%
Usd Price Per Share0.07-0.05-0.05-0.05-0.19-0.66-
Price to Earnings Ratio-24.59--8.39--2.25--4.08--5.44--21.22-
Price-to-Total Gains Ratio792.92-188.83--6.76-58.48-3.07-53.42-
Price to Book Ratio0.88-0.68-0.56-0.58-1.23-5.03-
Price-to-Total Gains Ratio792.92-188.83--6.76-58.48-3.07-53.42-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0498
Number of shares20080
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.01
Usd Total Gains Per Share0.00-0.01
Gains per Quarter (20080 shares)-58.53-132.31
Gains per Year (20080 shares)-234.11-529.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-234-2440-529-539
20-468-4780-1058-1068
30-702-7120-1588-1597
40-936-9460-2117-2126
50-1171-11800-2646-2655
60-1405-14140-3175-3184
70-1639-16480-3705-3713
80-1873-18820-4234-4242
90-2107-21160-4763-4771
100-2341-23500-5292-5300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.026.00.07.1%2.026.00.07.1%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%3.017.00.015.0%10.018.00.035.7%10.018.00.035.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.028.00.0%0.00.028.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%3.017.00.015.0%10.018.00.035.7%10.018.00.035.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Medipharm Labs Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.000-0.003+3549%-0.002+2084%-0.005+5816%-0.007+7898%0.003-97%
Book Value Per Share--0.0760.079-3%0.096-20%0.093-18%0.125-39%0.127-40%
Current Ratio--3.6123.272+10%3.349+8%3.908-8%4.560-21%4.112-12%
Debt To Asset Ratio--0.1700.191-11%0.186-9%0.173-2%0.184-8%0.212-20%
Debt To Equity Ratio--0.2040.236-14%0.228-10%0.210-3%0.234-13%0.290-30%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--21357695.53614389528.702+48%12829720.072+66%13909624.347+54%65749800.683-68%278438058.336-92%
Eps---0.001-0.003+383%-0.006+779%-0.006+851%-0.014+1912%-0.011+1531%
Ev To Sales Ratio--0.6760.463+46%0.475+42%0.611+11%3.461-80%5.962-89%
Free Cash Flow Per Share---0.005-0.003-47%-0.005-8%-0.005-13%-0.007+28%-0.008+51%
Free Cash Flow To Equity Per Share---0.006-0.004-35%-0.005-17%-0.005-13%-0.002-57%-0.004-34%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.104----------
Intrinsic Value_10Y_min--0.079----------
Intrinsic Value_1Y_max---0.015----------
Intrinsic Value_1Y_min---0.014----------
Intrinsic Value_3Y_max---0.025----------
Intrinsic Value_3Y_min---0.024----------
Intrinsic Value_5Y_max---0.012----------
Intrinsic Value_5Y_min---0.013----------
Market Cap20673922.598-35%27814313.53622137287.602+26%21898582.672+27%21908961.147+27%78506937.803-65%273434272.898-90%
Net Profit Margin---0.036-0.178+397%-0.371+937%-0.573+1500%-1.339+3639%-1.023+2757%
Operating Margin----0%-0.1940%-0.3140%-1.0730%-0.8200%
Operating Ratio--1.6541.840-10%2.268-27%2.426-32%3.593-54%3.030-45%
Pb Ratio0.654-35%0.8800.678+30%0.558+58%0.578+52%1.225-28%5.026-82%
Pe Ratio-18.275+26%-24.587-8.392-66%-2.245-91%-4.082-83%-5.442-78%-21.222-14%
Price Per Share0.050-35%0.0670.053+26%0.053+27%0.053+27%0.189-65%0.659-90%
Price To Free Cash Flow Ratio-2.316+26%-3.116-5.828+87%-0.916-71%-3.944+27%-9.600+208%-7.158+130%
Price To Total Gains Ratio589.363-35%792.919188.833+320%-6.761+101%58.481+1256%3.069+25740%53.417+1384%
Quick Ratio--0.8410.639+32%0.696+21%0.917-8%1.241-32%1.049-20%
Return On Assets---0.007-0.033+345%-0.051+592%-0.058+683%-0.083+1015%-0.070+846%
Return On Equity---0.009-0.041+360%-0.063+605%-0.070+679%-0.103+1050%-0.088+886%
Total Gains Per Share--0.000-0.003+3549%-0.002+2084%-0.005+5816%-0.007+7898%0.003-97%
Usd Book Value--31593945.60032717002.500-3%39659237.100-20%38663095.800-18%52068074.940-39%52546967.817-40%
Usd Book Value Change Per Share--0.000-0.003+3549%-0.002+2084%-0.005+5816%-0.007+7898%0.003-97%
Usd Book Value Per Share--0.0760.079-3%0.096-20%0.093-18%0.125-39%0.127-40%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--21357695.53614389528.702+48%12829720.072+66%13909624.347+54%65749800.683-68%278438058.336-92%
Usd Eps---0.001-0.003+383%-0.006+779%-0.006+851%-0.014+1912%-0.011+1531%
Usd Free Cash Flow---2231863.200-1191569.400-47%-2061038.700-8%-1952758.500-13%-2857391.460+28%-2533866.300+14%
Usd Free Cash Flow Per Share---0.005-0.003-47%-0.005-8%-0.005-13%-0.007+28%-0.008+51%
Usd Free Cash Flow To Equity Per Share---0.006-0.004-35%-0.005-17%-0.005-13%-0.002-57%-0.004-34%
Usd Market Cap20673922.598-35%27814313.53622137287.602+26%21898582.672+27%21908961.147+27%78506937.803-65%273434272.898-90%
Usd Price Per Share0.050-35%0.0670.053+26%0.053+27%0.053+27%0.189-65%0.659-90%
Usd Profit---282819.600-1364769.000+383%-2485816.200+779%-2843421.000+905%-5781176.100+1944%-4679769.421+1555%
Usd Revenue--7897024.8007855369.200+1%6758073.000+17%6276902.100+26%5648353.200+40%7963605.900-1%
Usd Total Gains Per Share--0.000-0.003+3549%-0.002+2084%-0.005+5816%-0.007+7898%0.003-97%
 EOD+2 -6MRQTTM+24 -11YOY+25 -103Y+22 -135Y+21 -1410Y+16 -19

3.3 Fundamental Score

Let's check the fundamental score of Medipharm Labs Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-18.275
Price to Book Ratio (EOD)Between0-10.654
Net Profit Margin (MRQ)Greater than0-0.036
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.841
Current Ratio (MRQ)Greater than13.612
Debt to Asset Ratio (MRQ)Less than10.170
Debt to Equity Ratio (MRQ)Less than10.204
Return on Equity (MRQ)Greater than0.15-0.009
Return on Assets (MRQ)Greater than0.05-0.007
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Medipharm Labs Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.047
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Medipharm Labs Corp

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.

Fundamental data was last updated by Penke on 2025-06-30 18:20:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Medipharm Labs Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Medipharm Labs Corp to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -3.6%Β means thatΒ $-0.04 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Medipharm Labs Corp:

  • The MRQ is -3.6%. The company is making a loss. -1
  • The TTM is -17.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM-17.8%+14.2%
TTM-17.8%YOY-37.1%+19.3%
TTM-17.8%5Y-133.9%+116.1%
5Y-133.9%10Y-102.3%-31.6%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Medipharm Labs Corp is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Medipharm Labs Corp to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -0.7% Return on Assets means thatΒ Medipharm Labs Corp generatedΒ $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Medipharm Labs Corp:

  • The MRQ is -0.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.7%TTM-3.3%+2.6%
TTM-3.3%YOY-5.1%+1.8%
TTM-3.3%5Y-8.3%+5.0%
5Y-8.3%10Y-7.0%-1.3%
4.3.1.3. Return on Equity

Shows how efficient Medipharm Labs Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Medipharm Labs Corp to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -0.9% Return on Equity means Medipharm Labs Corp generated $-0.01Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Medipharm Labs Corp:

  • The MRQ is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-4.1%+3.2%
TTM-4.1%YOY-6.3%+2.2%
TTM-4.1%5Y-10.3%+6.2%
5Y-10.3%10Y-8.8%-1.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Medipharm Labs Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Medipharm Labs Corp is operatingΒ .

  • Measures how much profit Medipharm Labs Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Medipharm Labs Corp to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Medipharm Labs Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-19.4%+19.4%
TTM-5Y-107.3%+107.3%
5Y-107.3%10Y-82.0%-25.3%
4.3.2.2. Operating Ratio

Measures how efficient Medipharm Labs Corp is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.65 means that the operating costs are $1.65 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Medipharm Labs Corp:

  • The MRQ is 1.654. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.840. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.654TTM1.840-0.186
TTM1.840YOY2.268-0.428
TTM1.8405Y3.593-1.753
5Y3.59310Y3.030+0.563
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Medipharm Labs Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Medipharm Labs Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.61Β means the company has $3.61 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Medipharm Labs Corp:

  • The MRQ is 3.612. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.272. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.612TTM3.272+0.340
TTM3.272YOY3.349-0.077
TTM3.2725Y4.560-1.288
5Y4.56010Y4.112+0.448
4.4.3.2. Quick Ratio

Measures if Medipharm Labs Corp is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Medipharm Labs Corp to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.84Β means the company can pay off $0.84 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Medipharm Labs Corp:

  • The MRQ is 0.841. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.639. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.841TTM0.639+0.202
TTM0.639YOY0.696-0.056
TTM0.6395Y1.241-0.601
5Y1.24110Y1.049+0.191
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Medipharm Labs Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Medipharm Labs CorpΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Medipharm Labs Corp to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.17Β means that Medipharm Labs Corp assets areΒ financed with 17.0% credit (debt) and the remaining percentage (100% - 17.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Medipharm Labs Corp:

  • The MRQ is 0.170. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.191. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.170TTM0.191-0.021
TTM0.191YOY0.186+0.005
TTM0.1915Y0.184+0.007
5Y0.18410Y0.212-0.028
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Medipharm Labs Corp is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Medipharm Labs Corp to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 20.4% means that company has $0.20 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Medipharm Labs Corp:

  • The MRQ is 0.204. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.236. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.204TTM0.236-0.032
TTM0.236YOY0.228+0.008
TTM0.2365Y0.234+0.002
5Y0.23410Y0.290-0.056
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Medipharm Labs Corp generates.

  • Above 15 is considered overpriced butΒ always compareΒ Medipharm Labs Corp to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -24.59 means the investor is paying $-24.59Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Medipharm Labs Corp:

  • The EOD is -18.275. Based on the earnings, the company is expensive. -2
  • The MRQ is -24.587. Based on the earnings, the company is expensive. -2
  • The TTM is -8.392. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-18.275MRQ-24.587+6.312
MRQ-24.587TTM-8.392-16.195
TTM-8.392YOY-2.245-6.147
TTM-8.3925Y-5.442-2.950
5Y-5.44210Y-21.222+15.780
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Medipharm Labs Corp:

  • The EOD is -2.316. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.116. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.828. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.316MRQ-3.116+0.800
MRQ-3.116TTM-5.828+2.712
TTM-5.828YOY-0.916-4.912
TTM-5.8285Y-9.600+3.772
5Y-9.60010Y-7.158-2.442
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Medipharm Labs Corp is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.88 means the investor is paying $0.88Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Medipharm Labs Corp:

  • The EOD is 0.654. Based on the equity, the company is cheap. +2
  • The MRQ is 0.880. Based on the equity, the company is cheap. +2
  • The TTM is 0.678. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.654MRQ0.880-0.226
MRQ0.880TTM0.678+0.203
TTM0.678YOY0.558+0.120
TTM0.6785Y1.225-0.547
5Y1.22510Y5.026-3.801
4.6.2. Total Gains per Share

2.4. Latest News of Medipharm Labs Corp

Does Medipharm Labs Corp still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Medipharm Labs Corp to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-14
15:10
Medipharm announces Glass Lewis recommends shareholders vote for all nomineesRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets52,067
Total Liabilities8,835
Total Stockholder Equity43,232
 As reported
Total Liabilities 8,835
Total Stockholder Equity+ 43,232
Total Assets = 52,067

Assets

Total Assets52,067
Total Current Assets31,802
Long-term Assets20,265
Total Current Assets
Cash And Cash Equivalents 8,443
Net Receivables 7,407
Inventory 10,594
Other Current Assets 268
Total Current Assets  (as reported)31,802
Total Current Assets  (calculated)26,712
+/- 5,090
Long-term Assets
Property Plant Equipment 18,821
Intangible Assets 809
Long-term Assets  (as reported)20,265
Long-term Assets  (calculated)19,630
+/- 635

Liabilities & Shareholders' Equity

Total Current Liabilities8,804
Long-term Liabilities31
Total Stockholder Equity43,232
Total Current Liabilities
Short Long Term Debt 14
Accounts payable 4,890
Total Current Liabilities  (as reported)8,804
Total Current Liabilities  (calculated)4,904
+/- 3,900
Long-term Liabilities
Long-term Liabilities  (as reported)31
Long-term Liabilities  (calculated)0
+/- 31
Total Stockholder Equity
Total Stockholder Equity (as reported)43,232
Total Stockholder Equity (calculated)0
+/- 43,232
Other
Capital Stock201,216
Common Stock Shares Outstanding 415,139
Net Invested Capital 43,246
Net Working Capital 22,998
Property Plant and Equipment Gross 42,524



6.2. Balance Sheets Structured

Currency in CAD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
3,431
31,001
42,729
70,138
174,319
183,024
168,830
143,775
178,765
150,227
118,231
137,328
128,184
118,199
92,361
84,580
79,241
71,234
65,495
62,051
73,522
68,007
63,937
61,245
59,841
55,844
53,730
52,067
52,06753,73055,84459,84161,24563,93768,00773,52262,05165,49571,23479,24184,58092,361118,199128,184137,328118,231150,227178,765143,775168,830183,024174,31970,13842,72931,0013,4310
   > Total Current Assets 
0
2,886
17,905
26,614
45,650
142,922
140,853
119,701
93,351
127,656
101,008
81,521
101,624
94,023
84,883
65,547
58,300
54,309
52,182
47,345
44,366
46,702
41,672
36,633
34,777
37,922
34,567
33,082
31,802
31,80233,08234,56737,92234,77736,63341,67246,70244,36647,34552,18254,30958,30065,54784,88394,023101,62481,521101,008127,65693,351119,701140,853142,92245,65026,61417,9052,8860
       Cash And Cash Equivalents 
0
2,234
6,383
7,850
8,400
72,723
42,116
38,627
21,366
27,946
36,458
19,913
42,124
38,751
37,958
34,110
28,273
21,992
19,454
24,145
20,150
14,742
12,950
17,981
16,926
15,991
13,092
11,690
8,443
8,44311,69013,09215,99116,92617,98112,95014,74220,15024,14519,45421,99228,27334,11037,95838,75142,12419,91336,45827,94621,36638,62742,11672,7238,4007,8506,3832,2340
       Short-term Investments 
0
16
442
400
200
200
200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000200200200400442160
       Net Receivables 
0
109
1,734
6,427
13,884
25,361
40,786
27,540
24,836
37,593
29,822
34,137
32,265
36,891
29,152
16,918
14,860
14,791
13,736
12,345
13,773
13,882
8,046
5,515
6,217
5,870
6,228
6,878
7,407
7,4076,8786,2285,8706,2175,5158,04613,88213,77312,34513,73614,79114,86016,91829,15236,89132,26534,13729,82237,59324,83627,54040,78625,36113,8846,4271,7341090
       Other Current Assets 
0
75
1,837
2,332
565
35
287
0
0
18,911
3,045
2,841
3,082
4,722
3,382
1,343
3,280
879
7,907
146
2,319
4,311
391
194
306
337
233
213
268
2682132333373061943914,3112,3191467,9078793,2801,3433,3824,7223,0822,8413,04518,91100287355652,3321,837750
   > Long-term Assets 
0
0
0
0
24,488
31,397
42,171
49,129
50,424
51,109
49,219
36,710
35,704
34,161
33,316
26,814
26,280
24,932
19,052
18,150
17,685
26,820
26,335
27,304
26,468
21,919
21,277
20,648
20,265
20,26520,64821,27721,91926,46827,30426,33526,82017,68518,15019,05224,93226,28026,81433,31634,16135,70436,71049,21951,10950,42449,12942,17131,39724,4880000
       Property Plant Equipment 
0
539
13,046
13,968
15,837
24,302
34,919
42,233
43,962
45,552
44,808
34,144
33,121
31,587
30,620
25,894
25,364
24,468
18,588
18,111
17,647
25,935
25,258
25,272
24,496
20,071
19,631
19,159
18,821
18,82119,15919,63120,07124,49625,27225,25825,93517,64718,11118,58824,46825,36425,89430,62031,58733,12134,14444,80845,55243,96242,23334,91924,30215,83713,96813,0465390
       Long Term Investments 
0
6
50
81
157
189
189
189
191
191
191
191
191
191
191
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000191191191191191191191189189189157815060
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
228
244
236
228
44
43
41
41
39
38
885
1,077
1,032
987
943
898
854
809
8098548989439871,0321,07788538394141434422823624422800000000000
       Other Assets 
0
0
0
2,066
8,494
6,906
7,063
6,707
6,271
5,366
4,220
2,147
2,148
2,147
2,277
876
873
423
423
0
0
0
0
0
0
0
0
0
0
00000000004234238738762,2772,1472,1482,1474,2205,3666,2716,7077,0636,9068,4942,066000
> Total Liabilities 
0
554
7,195
14,886
35,748
53,201
54,045
37,603
25,682
61,543
45,964
39,817
18,572
18,657
15,583
9,215
8,425
10,674
10,756
9,490
8,387
14,512
12,804
10,932
11,390
12,231
10,795
10,546
8,835
8,83510,54610,79512,23111,39010,93212,80414,5128,3879,49010,75610,6748,4259,21515,58318,65718,57239,81745,96461,54325,68237,60354,04553,20135,74814,8867,1955540
   > Total Current Liabilities 
0
554
7,195
14,886
35,748
53,201
53,561
28,846
25,129
39,949
14,661
24,245
17,906
18,391
15,457
8,877
8,104
10,383
10,706
9,456
8,369
12,684
12,725
10,863
11,332
12,184
10,760
10,495
8,804
8,80410,49510,76012,18411,33210,86312,72512,6848,3699,45610,70610,3838,1048,87715,45718,39117,90624,24514,66139,94925,12928,84653,56153,20135,74814,8867,1955540
       Short-term Debt 
0
0
0
0
0
0
6,000
1,459
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001,4596,000000000
       Short Long Term Debt 
0
0
0
0
6,000
6,000
6,000
1,459
9,351
1,257
7,382
7,375
3,102
1,732
1,968
0
0
1,291
1,038
523
131
963
2,463
2,105
1,977
2,711
571
258
14
142585712,7111,9772,1052,4639631315231,0381,291001,9681,7323,1027,3757,3821,2579,3511,4596,0006,0006,0000000
       Accounts payable 
0
329
4,990
8,094
20,356
43,605
41,636
19,057
11,697
5,646
2,116
5,549
2,646
6,628
5,976
2,991
2,795
3,519
3,694
3,539
6,326
3,722
2,422
2,130
3,619
2,650
3,508
4,237
4,890
4,8904,2373,5082,6503,6192,1302,4223,7226,3263,5393,6943,5192,7952,9915,9766,6282,6465,5492,1165,64611,69719,05741,63643,60520,3568,0944,9903290
       Other Current Liabilities 
0
1
14
50
392
633
716
4,823
537
24,602
1,288
1,752
3,475
2,387
2,629
1,628
1,682
1,887
2,916
829
0
1,387
829
829
0
0
0
0
0
000008298291,38708292,9161,8871,6821,6282,6292,3873,4751,7521,28824,6025374,823716633392501410
   > Long-term Liabilities 
0
0
0
0
0
0
484
8,757
553
21,594
31,303
15,572
666
266
126
338
321
291
50
34
18
1,828
79
69
58
47
35
51
31
315135475869791,82818345029132133812626666615,57231,30321,5945538,757484000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
6,933
7,655
4,811
518
174
20
235
234
221
0
0
0
0
0
0
0
0
0
0
0
00000000000221234235201745184,8117,6556,933000000000
> Total Stockholder Equity
2,873
2,881
23,579
27,649
34,259
121,019
128,981
131,547
118,665
117,981
105,386
78,414
118,756
109,527
102,616
83,146
76,155
68,567
60,478
56,005
53,664
59,010
55,203
53,005
49,855
47,610
45,049
43,184
43,232
43,23243,18445,04947,61049,85553,00555,20359,01053,66456,00560,47868,56776,15583,146102,616109,527118,75678,414105,386117,981118,665131,547128,981121,01934,25927,64923,5792,8812,873
   Common Stock
0
3,063
27,460
34,065
38,474
120,602
121,062
122,807
124,166
125,517
127,619
138,508
186,434
188,609
188,603
190,550
190,634
190,841
191,008
0
191,256
0
0
0
0
0
0
0
0
00000000191,2560191,008190,841190,634190,550188,603188,609186,434138,508127,619125,517124,166122,807121,062120,60238,47434,06527,4603,0630
   Retained Earnings Total Equity00000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000
   Capital Surplus 00000000000000000000000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
274
2,164
3,418
6,129
8,762
12,888
16,929
19,776
21,095
21,358
14,448
20,731
21,140
21,590
21,939
22,321
23,513
23,187
0
29,145
0
0
0
0
0
0
0
0
0000000029,145023,18723,51322,32121,93921,59021,14020,73114,44821,35821,09519,77616,92912,8888,7626,1293,4182,1642740



6.3. Balance Sheets

Currency in CAD. All numbers in thousands.




6.4. Cash Flows

Currency in CAD. All numbers in thousands.




6.5. Income Statements

Currency in CAD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in CAD. All numbers in thousands.

Gross Profit (+$)
totalRevenue41,961
Cost of Revenue-29,156
Gross Profit12,80512,805
 
Operating Income (+$)
Gross Profit12,805
Operating Expense-52,529
Operating Income-10,568-39,724
 
Operating Expense (+$)
Research Development235
Selling General Administrative22,856
Selling And Marketing Expenses-
Operating Expense52,52923,091
 
Net Interest Income (+$)
Interest Income691
Interest Expense-576
Other Finance Cost-0
Net Interest Income115
 
Pretax Income (+$)
Operating Income-10,568
Net Interest Income115
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-10,694-10,327
EBIT - interestExpense = -576
-10,694
-10,118
Interest Expense576
Earnings Before Interest and Taxes (EBIT)--10,118
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-10,694
Tax Provision-0
Net Income From Continuing Ops-10,694-10,694
Net Income-10,694
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-241-115
 

Technical Analysis of Medipharm Labs Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medipharm Labs Corp. The general trend of Medipharm Labs Corp is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medipharm Labs Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Medipharm Labs Corp Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Medipharm Labs Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.067 < 0.067 < 0.081.

The bearish price targets are: 0.046 > 0.038 > 0.038.

Know someone who trades $MEDIF? Share this with them.πŸ‘‡

Medipharm Labs Corp Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Medipharm Labs Corp. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Medipharm Labs Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Medipharm Labs Corp.

Medipharm Labs Corp Daily Moving Average Convergence/Divergence (MACD) ChartMedipharm Labs Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Medipharm Labs Corp. The current adx is .

Medipharm Labs Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Medipharm Labs Corp.

Medipharm Labs Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Medipharm Labs Corp.

Medipharm Labs Corp Daily Relative Strength Index (RSI) ChartMedipharm Labs Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Medipharm Labs Corp.

Medipharm Labs Corp Daily Stochastic Oscillator ChartMedipharm Labs Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Medipharm Labs Corp.

Medipharm Labs Corp Daily Commodity Channel Index (CCI) ChartMedipharm Labs Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Medipharm Labs Corp.

Medipharm Labs Corp Daily Chande Momentum Oscillator (CMO) ChartMedipharm Labs Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Medipharm Labs Corp.

Medipharm Labs Corp Daily Williams %R ChartMedipharm Labs Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Medipharm Labs Corp.

Medipharm Labs Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Medipharm Labs Corp.

Medipharm Labs Corp Daily Average True Range (ATR) ChartMedipharm Labs Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Medipharm Labs Corp.

Medipharm Labs Corp Daily On-Balance Volume (OBV) ChartMedipharm Labs Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Medipharm Labs Corp.

Medipharm Labs Corp Daily Money Flow Index (MFI) ChartMedipharm Labs Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Medipharm Labs Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Medipharm Labs Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Medipharm Labs Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.047
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Medipharm Labs Corp with someone you think should read this too:
  • Are you bullish or bearish on Medipharm Labs Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medipharm Labs Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Medipharm Labs Corp

I send you an email if I find something interesting about Medipharm Labs Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Medipharm Labs Corp.

Receive notifications about Medipharm Labs Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.